Atorvastatin effect on COVID-19 outcomes: a propensity score matched study on hospitalized patients (2025)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.2174/0109298673264305231025093939
- Subjects: ESTUDOS RETROSPECTIVOS; COVID-19; FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO; PACIENTES INTERNADOS
- Agências de fomento:
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Current Medicinal Chemistry
- ISSN: 0929-8673
- Volume/Número/Paginação/Ano: v. 32, n. 14, p. 2824-2837, 2025
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
POURHOSEINGHOLI, Mohamad Amin et al. Atorvastatin effect on COVID-19 outcomes: a propensity score matched study on hospitalized patients. Current Medicinal Chemistry, v. 32, n. 14, p. 2824-2837, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87128. Acesso em: 02 abr. 2026. -
APA
Pourhoseingholi, M. A., Yazdani, O., Looha, M. A., Safavi-naini, S. A. A., Esbati, R., Ilkhani, S., et al. (2025). Atorvastatin effect on COVID-19 outcomes: a propensity score matched study on hospitalized patients. Current Medicinal Chemistry, 32( 14), 2824-2837. doi:10.2174/0109298673264305231025093939 -
NLM
Pourhoseingholi MA, Yazdani O, Looha MA, Safavi-naini SAA, Esbati R, Ilkhani S, Taraghikhah N, Hatamabadi H, Sadeghi A, Santos Filho RD dos. Atorvastatin effect on COVID-19 outcomes: a propensity score matched study on hospitalized patients [Internet]. Current Medicinal Chemistry. 2025 ; 32( 14): 2824-2837.[citado 2026 abr. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87128 -
Vancouver
Pourhoseingholi MA, Yazdani O, Looha MA, Safavi-naini SAA, Esbati R, Ilkhani S, Taraghikhah N, Hatamabadi H, Sadeghi A, Santos Filho RD dos. Atorvastatin effect on COVID-19 outcomes: a propensity score matched study on hospitalized patients [Internet]. Current Medicinal Chemistry. 2025 ; 32( 14): 2824-2837.[citado 2026 abr. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87128 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
